MARKER THERAPEUTICS INC (MRKR)
US57055L2060 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to MRKR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 12.75. This target is 210.22% above the current price.
MRKR was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about MRKR.
In the previous month the buy percentage consensus was at a similar level.
MRKR was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-30 | Ladenburg Thalmann | Initiate | Buy |
| 2022-02-17 | Roth Capital | Downgrade | Buy -> Neutral |
| 2021-03-25 | Piper Sandler | Initiate | Overweight |
| 2021-03-19 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-03-18 | Cantor Fitzgerald | Initiate | Overweight |